Use of PCR-based assays for the detection of the adventitious agent porcine circovirus type 1 (PCV1) in vaccines, and for confirming the identity of cell substrates and viruses used in vaccine production

Journal of Virological Methods

Volumn 179, Issue 1, 2012, Pages 201-211

  Kumar, Deepak ^a   Beach, Nathan M ^b   Meng, Xiang Jin ^b   Hegde, Nagendra R ^a  

^a Ella Foundation   (India)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Adventitious agents; Cell identity; Polymerase chain reaction (PCR); Porcine circovirus (PCV); Vaccine quality; Virus identity

Indexed keywords

BIOPOLIO; HN VAC; INDIRAB; INFLUENZA VACCINE; JENVAC; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE; ROTAVAC; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CIRCOVIRUS; DNA SEQUENCE; DNA TEMPLATE; DRUG CONTAMINATION; DRUG MANUFACTURE; GENOTYPE; HUMAN; MATERIAL STATE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PORCINE CIRCOVIRUS TYPE 1; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SEQUENCE ALIGNMENT; STANDARDIZATION; VACCINE PRODUCTION; VIRUS DETECTION; VIRUS GENOME;

CIRCOVIRUS; DNA, VIRAL; HUMANS; INDIA; POLYMERASE CHAIN REACTION; QUALITY CONTROL; TECHNOLOGY, PHARMACEUTICAL; VACCINES; VIROLOGY;

PORCINE CIRCOVIRUS; PORCINE CIRCOVIRUS 1; ROTAVIRUS;

EID: 84855251365     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.10.017     Document Type: Article

References (83)

1. Alejandro M.B., Domingo J.D., Torres F.M. Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain. Hum. Vaccin. 2011, 7:798-799.
2. Allan G.M., Ellis J.A. Porcine circoviruses: a review. J. Vet. Diagn. Invest. 2000, 12:3-14.
3. Allan G., Krakowka S. Porcine circovirus 1. Information Presented at the Vaccines and Related Biological Products Advisory Committee Meeting 2010, http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM211852.ppt.
4. Allan G.M., McNeilly F., Cassidy J.P., Reilly G.A., Adair B., Ellis W.A., McNulty M.S. Pathogenesis of porcine circovirus: experimental infections of colostrum deprived piglets and examination of pig foetal material. Vet. Microbiol. 1995, 44:49-64.
5. Allan G.M., McNeilly F., McNair I., Curran M.D., Walker I., Ellis J., Konoby C., Meehan B. Absence of evidence for porcine circovirus type 2 in cattle and humans, and lack of seroconversion or lesions in experimentally infected sheep. Arch. Virol. 2000, 145:853-857.
6. Allan G.M., Phenix K.V., Todd D., McNulty M.S. Some biological and physico-chemical properties of porcine circovirus. Zentralbl. Veterinarmed. B 1994, 41:17-26.
7. Barbosa T., Zavala G., Cheng S. Molecular characterization of three recombinant isolates of avian leukosis virus obtained from contaminated Marek's disease vaccines. Avian Dis. 2008, 52:245-252.
8. Baylis S.A., Finsterbusch T., Bannert N., Blümel J., Mankertz A. Analysis of porcine circovirus type 1 detected in Rotarix vaccine. Vaccine 2010, 29:690-697.
9. Beach N.M., Cordoba L., Kenney S.P., Meng X.-J. Productive infection of human hepatocellular carcinoma cells by porcine circovirus type 1. Vaccine 2011, (Epub ahead of print). 10.1016/j.vaccine. 2011.06.097.
10. Beach N.M., Juhan N.M., Cordoba L., Meng X.J. Replacement of the replication factors of porcine circovirus (PCV) type 2 with those of PCV type 1 greatly enhances viral replication in vitro. J. Virol. 2010, 84:8986-8989.
11. Beach N.M., Ramamoorthy S., Opriessnig T., Wu S.Q., Meng X.J. Novel chimeric porcine circovirus (PCV) with the capsid gene of the emerging PCV2b subtype cloned in the genomic backbone of the non-pathogenic PCV1 is attenuated in vivo and induces protective and cross-protective immunity against PCV2b and PCV2a subtypes in pigs. Vaccine 2010, 29:22-232.
12. Bhan M.K., Lew J.F., Sazawal S., Das B.K., Gentsch J.R., Glass R.I. Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea. J. Infect. Dis. 1993, 168:282-287.
13. Bhandari N., Sharma P., Taneja S., Kumar T., Rongsen-Chandola T., Appaiahgari M.B., Mishra A., Singh S., Vrati S. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. J. Infect. Dis. 2009, 200:421-429.
14. Brunborg I.M., Moldal T., Jonassen C.M. Quantitation of porcine circovirus type 2 isolated from serum/plasma and tissue samples of healthy pigs and pigs with postweaning multisystemic wasting syndrome using a TaqMan-based real-time PCR. J. Virol. Methods 2004, 122:171-178.
15. ® (Rotavirus vaccine, live oral): GSK's PCV1 investigation. Meeting of the Advisory Committee on Immunization Practices 2010, http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-jun10/13-3-rota.pdf.
16. ® (Rotavirus vaccine, live, oral, pentavalent) update on porcine circovirus (PCV). Meeting of the Advisory Committee on Immunization Practices 2010, http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-jun10/13-4-rota.pdf.
17. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 1993, 15:532-537.
18. Cooper J.K., Sykes G., King S., Cottrill K., Ivanova N.V., Hanner R., Ikonomi P. Species identification in cell culture: a two-pronged molecular approach. In Vitro Cell. Dev. Biol. 2007, 43:344-351.
19. Cságola A., Cadar D., Tuboly T. Replication and transmission of porcine circovirus type 2 in mice. Acta Vet. Hung. 2008, 56:421-427.
20. Cunliffe N.A., Das B.K., Ramachandran M., Bhan M.K., Glass R.I., Gentsch J.R. Sequence analysis demonstrates that VP6, NSP1 and NSP4 genes of Indian neonatal rotavirus strain 116E are of human origin. Virus Genes 1997, 15:39-44.
21. Deng Z.B., Wang N.D., Xu D.J., Yuan A.W., Ge M., Luo W., Xue L.Q., Yu X.L. Viral distribution and lesions in Kunming mice experimentally infected with porcine circovirus type 2b. Vet. Res. Commun. 2011, 35:181-192.
22. Dulac G.C., Afshar A. Porcine circovirus antigens in PK15 cell line (ATCC CCL-33) and evidence of antibodies to circovirus in Canadian pigs. Can. J. Vet. Res. 1989, 53:431-433.
23. Ellis J.A., Wiseman B.M., Allan G., Konoby C., Krakowka S., Meehan B.M., McNeilly F. Analysis of seroconversion to porcine circovirus 2 among veterinarians from the United States and Canada. J. Am. Vet. Med. Assoc. 2000, 217:1645-1646.
24. Fadly A., Silva R., Hunt H., Pandiri A., Davis C. Isolation and characterization of an adventitious avian leukosis virus isolated from commercial Marek's disease vaccines. Avian Dis. 2006, 50:380-385.
25. FDA Draft Guidance for Industry: Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications 2010, Center for Biologics, Evaluation and Research, United States Food and Drug Administration. http://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/vaccines/ucm202439.pdf.
26. FDA Transcript of the Meeting of the Vaccines and Related Biological Products Advisory Committee Meeting 2010, http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM215266.pdf.
27. Fenaux M., Halbur P.G., Haqshenas G., Royer R., Thomas P., Nawagitgul P., Gill M., Toth T.E., Meng X.J. Cloned genomic DNA of type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease, virus distribution, and pathogenic lesions. J. Virol. 2002, 76:541-551.
28. Fenaux M., Opriessnig T., Halbur P.G., Meng X.-J. Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weaning pigs. J. Virol. 2003, 77:11232-11243.
29. Fenaux M., Opriessnig T., Halbur P.G., Xu Y., Potts B., Meng X.J. Detection and in vitro and in vivo characterization of porcine circovirus DNA from a porcine-derived commercial pepsin product. J. Gen. Virol. 2004, 85:3377-3382.
30. Geissler E., Konzer P., Scherneck S., Zimmermann W. Sera collected before introduction of contaminated polio vaccine contain antibodies against SV40. Acta Virol. 1985, 29:420-423.
31. Giangaspero M., Vacirca G., Harasawa R., Buttner M., Panuccio A., De Giuli Morghen C., Zanetti A., Belloli A., Verhulst A. Genotypes of pestivirus RNA detected in anti-influenza virus vaccines for human use. Vet. Ital. 2004, 40:7-21.
32. Glass R.I., Bhan M.K., Ray P., Bahl R., Parashar U.D., Greenberg H., Rao C.D., Bhandari N., Maldnado Y., Ward R.L., Bernstein D.I., Gentsch J.R. Development of candidate rotavirus vaccines derived from neonatal strains in India. J. Infect. Dis. 2005, 192(Suppl. 1):S30-S35.
33. Gooding L.R. Specificities of killing by T lymphocytes generated against syngeneic SV40 transformants: studies employing recombinants within the H-2 complex. J. Immunol. 1979, 122:1002-1008.
34. Harasawa R. Adventitious pestivirus RNA in live virus vaccines against bovine and swine diseases. Vaccine 1995, 13:100-103.
35. Hattermann K., Roedner C., Schmitt C., Finsterbusch T., Steinfeldt T., Mankertz A. Infection studies on human cell lines with porcine circovirus type 1 and porcine circovirus type 2. Xenotransplantation 2004, 11:284-294.
36. Hanke T., Graham F.L., Rosenthal K.L., Johnson D.C. Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. J. Virol. 1991, 65:1177-1185.
37. Häuptli D., Bruckner L., Ottiger H. Use of reverse transcriptase polymerase chain reaction for detection of vaccine contamination by avian leukosis virus. J. Virol. Methods 1997, 66:71-81.
38. Hilleman M.R. Discovery of simian virus 40 (SV40) and its relationship to poliomyelitis virus vaccines. Dev. Biol. Stand. 1998, 94:183-190.
39. Hussain A.I., Johnson J.A., Da Silva Freire M., Heneine W. Identification and characterization of avian retroviruses in chicken embryo-derived yellow fever vaccines: investigation of transmission to vaccine recipients. J. Virol. 2003, 77:1105-1111.
40. Hussain A.I., Shanmugam V., Switzer W.M., Tsang S.X., Fadly A., Thea D., Helfand R., Bellini W.J., Folks T.M., Heneine W. Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients. Emerg. Infect. Dis. 2001, 7:66-72.
41. ICTV Master Species List 2009. Version 8 2009, International Committee on Taxonomy of Viruses. http://talk.ictvonline.org/files/ictv_documents/m/msl/1231.aspx.
42. Jáuregui H.P., Ruiz M.A., Pastrana F.R., López G.D., Morales A.P., Betancourt E.T., Conde E. The porcine circovirus type 1 in porcine kidney 15 cell line is not transferred to mice lymphoid cells after xenoimplantation into the peritoneal cavity. Cell Transplant. 2010, 19:1209-1213.
43. Johnson J.A., Heneine W. Characterization of endogenous avian leukosis viruses in chicken embryonic fibroblast substrates used in production of measles and mumps vaccines. J. Virol. 2001, 75:3605-3612.
44. Karuppannan A.K., Kwang J. ORF3 of porcine circovirus 2 enhances the in vitro and in vivo spread of the virus. Virology 2011, 410:248-256.
45. Kniazeff A.J., Wopschall L.J., Hopps H.E., Morris C.S. Detection of bovine viruses in foetal bovine serum used in cell culture. In Vitro 1975, 11:400-403.
46. Krakowka S., Ellis J.A., McNeilly F., Ringler S., Rings D.M., Allan G. Activation of the immune system is the pivotal event in the production of wasting disease in pigs infected with porcine circovirus-2 (PCV2). Vet. Pathol. 2001, 38:31-42.
47. Kulcsar G., Farsang A., Soos T. Testing for viral contaminants of veterinary vaccines in Hungary. Biologicals 2010, 38:346-349.
48. Ladekjaer-Mikkelsen A.S., Nielsen J., Stadejek T., Storgaard T., Krakowka S., Ellis J., McNeilly F., Allan G., Botner A. Reproduction of postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and non-immunostimulated 3-week-old piglets experimentally infected with porcine circovirus type 2 (PCV2). Vet. Microbiol. 2002, 89:97-114.
49. Lewis A.M. SV40 in adenovirus vaccines and adenovirus-SV40 recombinants. Dev. Biol. Stand. 1998, 94:207-216.
50. Li L., Kapoor A., Slikas B., Bamidele O.S., Wang C., Shaukat S., Masroor M.A., Wilson M.L., Ndjango J.B., Peeters M., Gross-Camp N.D., Muller M.N., Hahn B.H., Wolfe N.D., Triki H., Bartkus J., Zaidi S.Z., Delwart E. Multiple diverse circoviruses infect farm animals and are commonly found in human and chimpanzee feces. J. Virol. 2010, 84:1674-1682.
51. Liu J., Chen I., Du Q., Chua H., Kwang J. The ORF3 protein of porcine circovirus type 2 is involved in viral pathogenesis in vivo. J. Virol. 2006, 80:5065-5073.
52. Ma H., Shaheduzzaman S., Williams D.K., Gao Y., Khan A.S. Investigations of porcine circovirus type 1 (PCV1) in vaccine-related and other cell lines. Vaccine 2011, (Epub ahead of print). 10.1016/j.vaccine.2011.07.123.
53. Martin I., Garcia T., Fajardo V., Rojas M., Hernandez P.E., Gonzalez I., Martin R. Technical note: detection of cat, dog, and rat or mouse tissues in food and animal feed using species-specific polymerase chain reaction. J. Anim. Sci. 2007, 85:2734-2739.
54. McClenahan S.D., Krause P.R., Uhlenhaut C. Molecular and infectivity studies of porcine circovirus in vaccines. Vaccine 2011, 29:4745-4753.
55. Olvera A., Cortey M., Segales J. Molecular evolution of porcine circovirus type 2 genomes: phylogeny and clonality. Virology 2007, 357:175-185.
56. Olvera A., Sibila M., Calsamiglia M., Segalés J., Domingo M. Comparison of porcine circovirus type 2 load in serum quantified by a real time PCR in postweaning multisystemic wasting syndrome and porcine dermatitis and nephropathy syndrome naturally affected pigs. J. Virol. Methods 2004, 117:75-80.
57. Ouardani M., Wilson L., Jetté R., Montpetit C., Dea S. Multiplex PCR for detection and typing of porcine circoviruses. J. Clin. Microbiol. 1999, 37:3917-3924.
58. Parodi B., Aresu O., Bini D., Lorenzini R., Schena F., Visconti P., Cesaro M., Ferrera D., Andreotti V., Ruzzon T. Species identification and confirmation of human and animal cell lines: a PCR-based method. BioTechniques 2002, 32:432-440.
59. Pastoret P.P. Human and animal vaccine contaminations. Biologicals 2010, 38:332-334.
60. Polak M.P., Rola J., zmudziński J.F. Contamination of foetal bovine serum with Bovine Viral Diarrhoea Virus (BVDV). Bull. Vet. Inst. Pulawy 2008, 52:501-505.
61. Quintana J., Balasch M., Segalés J., Calsamiglia M., Rodríguez-Arrioja G.M., Plana-Durán J., Domingo M. Experimental inoculation of porcine circoviruses type 1 (PCV1) and type 2 (PCV2) in rabbits and mice. Vet. Res. 2002, 33:229-237.
62. Quintana J., Segalés J., Calsamiglia M., Domingo M. Detection of porcine circovirus type 1 in commercial pig vaccines using polymerase chain reaction. Vet. J. 2006, 171:570-573.
63. Ramya R., Nagarajan T., Sivakumar V., Senthilkumar R.L., Bala Obulapathi B., Thiagarajan D., Srinivasan V.A. Identification of cross-contaminated animal cells by PCR and isoenzyme analysis. Cytotechnology 2009, 61:81-92.
64. Sacramento D., Badrane H., Bourhy H., Tordo N. Molecular epidemiology of rabies virus in France: comparison with vaccine strains. J. Gen. Virol. 1992, 73:1149-1158.
65. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 2001, Cold Spring Harbor Laboratory Press, New York. third ed.
66. Sangar D., Pipkin P.A., Wood D.J., Minor P.D. Examination of poliovirus vaccine preparations for SV40 sequences. Biologicals 1999, 27:1-10.
67. Sapkal G.N., Wairagkar N.S., Ayachit V.M., Bondre V.P., Gore M.M. Detection and isolation of Japanese encephalitis virus from blood clots collected during the acute phase of infection. Am. J. Trop. Med. Hyg. 2007, 77:1139-1145.
68. Sasaki T., Harasawa R., Shintani M., Fujiwara H., Sasaki Y., Horino A., Kenri T., Asada K., Kato I., Chino F. Application of PCR for detection of mycoplasma DNA and pestivirus RNA in human live viral vaccines. Biologicals 1996, 24:371-375.
69. Schweiger B., Schreier E., Bothig B., Lopez-Pila J.M. Differentiation of vaccine and wild-type polioviruses using polymerase chain reaction. Arch. Virol. 1994, 134:39-50.
70. Shahabuddin M., Sears J.F., Khan A.S. No evidence of infectious retroviruses in measles virus vaccines produced in chicken embryo cell cultures. J. Clin. Microbiol. 2001, 39:675-684.
71. Sofer G., Lister D.C., Boose J.A. Inactivation methods grouped by virus. Biopharm. Int. 2003, (June (Suppl.)):S37-S42.
72. Sorden S.D. Update on porcine circovirus and postweaning multisystemic wasting syndrome (PMWS). Swine Health Prod. 2000, 8:133-136.
73. Studer E., Bertoni G., Candrian U. Detection and characterization of pestivirus contaminations in human live viral vaccines. Biologicals 2002, 30:289-296.
74. Takagi M., Ishikawa K., Nagai H., Sasaki T., Gotoh K., Koyama H. Detection of contamination of vaccines with the reticuloendotheliosis virus by reverse transcriptase polymerase chain reaction (RT-PCR). Virus Res. 1996, 40:113-121.
75. Tischer I., Bode L., Peters D., Pociuli S., Germann B. Distribution of antibodies to porcine circovirus in swine populations of different breeding farms. Arch. Virol. 1995, 140:737-743.
76. Tischer I., Gelderblom H., Veltermann W., Koch M.A. A very small porcine virus with circular single-stranded DNA. Nature 1982, 295:64-66.
77. Tischer I., Mields W., Wolff D., Vagt M., Griem W. Studies on epidemiology and pathogenicity of porcine circovirus. Arch. Virol. 1986, 91:271-276.
78. Tischer I., Rasch R., Tochtermann G. Characterization of a papovavirus and picornavirus-like particles in permanent pig kidney cell lines. Zentralbl. Bakteriol. A 1974, 226:153-167.
79. Tsang S.X., Switzer W.M., Shanmugam V., Johnson J.A., Goldsmith C., Wright A., Fadly A., Thea D., Jaffe H., Folks T.M., Heneine W. Evidence of avian leukosis virus subgroup E and endogenous avian virus in measles and mumps vaccines derived from chicken cells: investigation of transmission to vaccine recipients. J. Virol. 1999, 73:5843-5851.
80. Victoria J., Wang C., Jones M., Jaing C., McLoughlin K., Gardner S., Delwart E.L. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J. Virol. 2010, 84:6033-6040.
81. Welch J., Bienek C., Gomperts E., Simmonds P. Resistance of porcine circovirus and chicken anemia virus to virus inactivation procedures used for blood products. Transfusion 2006, 46:1951-1958.
82. WHO Information for Laboratory Diagnosis of Pandemic (H1N1) 2009 Virus in Humans 2009, World Health Organization. http://www.who.int/csr/resources/publications/swineflu/WHO_Diagnostic_RecommendationsH1N1_20090521.pdf.
83. Yanagi M., Bukh J., Emerson S.U., Purcell R.H. Contamination of commercially available fetal bovine sera with bovine viral diarrhea virus genomes: Implications for the study of hepatitis C virus in cell cultures. J. Infect. Dis. 1996, 174:1324-1327.